Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Long-Term Debt Repayments: 2010-2012

Historic Long-Term Debt Repayments for Lexicon Pharmaceuticals (LXRX) over the last 2 years, with Dec 2012 value amounting to $375,000.

  • Lexicon Pharmaceuticals' Long-Term Debt Repayments rose 8.70% to $375,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $1.4 million, marking a year-over-year decrease of 59.79%. This contributed to the annual value of $50.0 million for FY2023, which is 2.24% up from last year.
  • As of Q4 2012, Lexicon Pharmaceuticals' Long-Term Debt Repayments stood at $375,000, which was up 3.59% from $362,000 recorded in Q3 2012.
  • Lexicon Pharmaceuticals' Long-Term Debt Repayments' 5-year high stood at $16.3 million during Q3 2010, with a 5-year trough of $271,000 in Q4 2010.
  • For the 3-year period, Lexicon Pharmaceuticals' Long-Term Debt Repayments averaged around $2.2 million, with its median value being $353,000 (2012).
  • Within the past 5 years, the most significant YoY rise in Lexicon Pharmaceuticals' Long-Term Debt Repayments was 27.31% (2011), while the steepest drop was 97.98% (2011).
  • Lexicon Pharmaceuticals' Long-Term Debt Repayments (Quarterly) stood at $271,000 in 2010, then increased by 27.31% to $345,000 in 2011, then climbed by 8.70% to $375,000 in 2012.
  • Its Long-Term Debt Repayments was $375,000 in Q4 2012, compared to $362,000 in Q3 2012 and $353,000 in Q2 2012.